Matthew Miessau is a Principal at Epidarex Capital, where he handles deal sourcing, due diligence, and portfolio management. He previously managed the Georgetown University Center for Drug Discovery and teaches at the NIH Foundation for Advanced Education in the Sciences.
What Matthew can write
Career
- Georgetown University Center for Drug Discovery · Program Manager
- Epidarex Capital · AnalystNow
- Epidarex Capital · PrincipalNow
Investments named in public bios
Focus
Education
Also at Epidarex Capital
Partners like Matthew
At firms with a similar stage, sector and check size.
Alert me when Epidarex Capital is active
One email when Matthew's firm raises a fund, adds a partner or shows new activity.
Send Mode VC your deck
Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckQuestions
Who is Matthew Miessau?
Matthew Miessau is a Principal at Epidarex Capital, where he handles deal sourcing, due diligence, and portfolio management. He previously managed the Georgetown University Center for Drug Discovery and teaches at the NIH Foundation for Advanced Education in the Sciences.
How much does Matthew Miessau invest?
Epidarex Capital has not reported a check size. It invests at seed, series a.
How do I pitch Matthew Miessau?
Email [email protected], the firm's inbox for founders, and name Matthew in the subject. A warm intro from a founder Epidarex Capital backed works better.
What did Matthew Miessau do before Epidarex Capital?
Program Manager at Georgetown University Center for Drug Discovery.
Last updated 2026-10-15. Is this you? Ask for a correction.